A new paper shows Cleveland Clinic’s AI scribe rollout is paying dividends in clinician satisfaction and retention. These are key metrics for hospitals to track, given they spend millions on recruitment and retention efforts amid an ongoing workforce crisis. The post Ambient Scribes Improve Clinician Retention, Cleveland Clinic Research Shows appeared first on MedCity News.

Abcuro will apply the capital to a study that could support a biologics license application in inclusion body myositis, a rare inflammatory disorder that leads to worsening muscle weakness. A Phase 2/3 study failed earlier this year, but Abcuro saw positive trends in patients with less severe disease. The post Abcuro Adds $66M to Try Again in Rare Inflammatory Disorder With No Approved Drugs appeared first on MedCity News.

Cityblock Health plans to acquire rural healthcare provider Homeward Health and has raised $116 million to expand its value-based care model to rural and Medicare Advantage populations. The post Cityblock to Acquire Homeward Health, Secures $116M Series E appeared first on MedCity News.

But the deadline that most people are not tracking, and the most worrisome, is October 1, 2026. It’s the day federal Medicaid funding ends for the country’s most vulnerable populations, including refugees, asylees, and humanitarian parolees. The post How to Prepare Your Hospital Before H.R. 1 Hits in 2027 appeared first on MedCity News.

Epic faced an FTC antitrust probe this week, but that didn’t stop the EHR giant from unveiling a wave of new AI tools at its annual conference. The post This Week In Epic News: FTC Probe, AI Agents & More appeared first on MedCity News.

Along with Ambros Therapeutics’ merger with Werewolf Therapeutics, the combined company will raise $150 million in a private placement. Ambros is in Phase 3 testing with a drug developed for treating a type of pain that does not respond to currently available medicines, including opioids. The post Ambros Therapeutics’ Path for Pain Drug Goes Through Reverse Merger With Werewolf appeared first on MedCity News.

Today, 3D modeling and printing technology can make a dramatic impact — even shortening some operations by 30-90 minutes. Looking ahead, that reduction will only grow as the technology is further integrated and becomes more advanced. The post The Pulse of Innovation: How 3D Models Can Prepare Surgeons for the Operating Room appeared first on MedCity News.

Gaps in reimbursement oversight and recovery will only widen, unless plans modernize how they detect, investigate, and recoup improper payments. The post Modernizing Payment Integrity in an Era of Systemic Fraud appeared first on MedCity News.

SCAN Health Plan and Costco are partnering to provide a suite of insurance products for seniors. The post SCAN, Costco Launch Medicare Partnership appeared first on MedCity News.

Ultragenyx Pharmaceutical’s Genglycos received accelerated FDA approval for glycogen storage disease type Ia, an inherited enzyme deficiency. It’s also the first approved gene therapy for Ultragenyx, which specializes in rare disease treatments. The post Ultragenyx Gene Therapy Becomes First FDA-Approved Treatment for Ultra-Rare Disease appeared first on MedCity News.

Why the flood of consumer wellness devices demands clear boundaries between lifestyle improvement and clinical diagnostics The post The Imperative of Distinguishing Medical-Grade Devices from Wellness Tech appeared first on MedCity News.

As adoption accelerates, organizations must ensure that the use of AI strengthens and not weakens accountability and patient safety.   The post AI in Pharmacovigilance: Why Governance Will Define Success appeared first on MedCity News.

Happy Health’s $75 million round was from ARCH Venture Partners and OpenLoop. The post Happy Health Snags $75M to Support Home-Based Care appeared first on MedCity News.

Merck and Moderna said intismeran autogene, an mRNA cancer vaccine that prompts an immune response to proteins expressed by a patient’s tumors, met the main goal of a pivotal test in melanoma. It’s the most advanced trial in a 50/50 partnership evaluating the personalized cancer treatment in a wide range of tumor types. The post Merck, Moderna Personalized mRNA Cancer Therapy Achieves a First for Melanoma appeared first on MedCity News.

The next healthcare revolution isn’t about treating osteoporosis, it’s about preserving mobility and healthspan. The post Why Bone Health Is Preventive Healthcare’s Next Big Category appeared first on MedCity News.